United States Tardive Dyskinesia Treatment Market 2025 | Growth Drivers, Competitive Landscape & Investment Opportunities

Market size and Growth

The U.S. Tardive Dyskinesia Treatment market is expected to reach US$ 6417.43 million in 2031, from its recorded value of US$ 3061.64 million in 2023, exhibiting a CAGR of 9.8% during the forecast period.

Key Development:

United States: Recent Industry Developments

✅ In May 2025, Teva Pharmaceuticals presented data at Psych Congress Elevate 2025, revealing that over half of TD patients in long-term care settings are undertreated. The company emphasized the need for improved diagnosis and treatment initiation in these settings.

✅ In April 2025, Neurocrine Biosciences launched the granule formulation of Ingrezza, named Ingrezza Sprinkle, approved by the U.S. FDA. This new form is designed for patients with difficulty swallowing capsules, expanding accessibility for TD treatment.

Japan: Recent Industry Developments

✅ In 2025, Neurocrine Biosciences' Ingrezza received approval in Japan for the treatment of TD. This marks a significant milestone in expanding access to effective TD therapies in the region.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/us-tardive-dyskinesia-treatment-market?sb

Tardive dyskinesia treatment refers to therapies aimed at managing involuntary, repetitive movements caused by long-term use of antipsychotic medications. Treatments include medications such as VMAT2 inhibitors, dose adjustments, and supportive therapies, which help reduce symptoms, improve motor control, and enhance patient quality of life.

Key Players:

=> Teva Pharmaceutical Industries Ltd, Neurocrine Biosciences, Inc., Lupin Limited, Accord Healthcare, Inc., Mitsubishi Corporation, Dr. Reddy's Laboratories Limited, BIONPHARMA INC., Slate Run Pharmaceuticals, Aurobindo Pharma Limited, Apotex Inc.

Growth Forecast Projected:

The Global Tardive Dyskinesia Treatment Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Tardive Dyskinesia Treatment Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=us-tardive-dyskinesia-treatment-market

Key Segments:

➥ By Drug: Valbenazine, Deutetrabenazine, Tetrabenazine, Clonazepam, Amantadine, Others

➥ By Distribution Channel: Hospital and Specialty Pharmacies, Retail Pharmacies, Others

Regional Analysis for Tardive Dyskinesia Treatment Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among Tardive Dyskinesia Treatment producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze Tardive Dyskinesia Treatment revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/us-tardive-dyskinesia-treatment-market?sb

FAQ

What is the current size of the Tardive Dyskinesia Treatment Market?

A: In 2023, the Tardive Dyskinesia Treatment Market was valued at US$ 3061.64 million, reflecting its strong industry presence.

Q2: How large is the Tardive Dyskinesia Treatment Market expected to be by 2031?

A: By 2031, industry forecasts suggest the Tardive Dyskinesia Treatment Market will grow to around US$ 6417.43 million, demonstrating significant expansion.

Q3: What is the growth rate of the Tardive Dyskinesia Treatment Market?

A: The market is projected to expand at a compound annual growth rate (CAGR) of 9.8% during the forecast period from 2024 to 2031.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.